Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients.

Soysal SD, Ng CKY, Costa L, Weber WP, Paradiso V, Piscuoglio S, Muenst S.

Front Med (Lausanne). 2019 Jul 24;6:166. doi: 10.3389/fmed.2019.00166. eCollection 2019.

2.

Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial).

Hench IB, Cathomas R, Costa L, Fischer N, Gillessen S, Hench J, Hermanns T, Kremer E, Mingrone W, Mestre RP, Püschel H, Rothermundt C, Ruiz C, Tolnay M, Burg PV, Bubendorf L, Vlajnic T, Sakk SGFCCR.

Cancers (Basel). 2019 Aug 1;11(8). pii: E1099. doi: 10.3390/cancers11081099.

3.

Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD.

Mandal J, Roth M, Papakonstantinou E, Sun Q, Costa L, Boeck L, Scherr A, Rakic J, Louis R, Milenkovic B, Boersma W, Kostikas K, Blasi F, Aerts J, Rohde G, Lacoma A, Torres A, Welte T, Tamm M, Stolz D.

Pulm Pharmacol Ther. 2018 Feb;48:111-116. doi: 10.1016/j.pupt.2017.10.011. Epub 2017 Oct 21.

PMID:
29066215
4.

The MNK-1/eIF4E pathway as a new therapeutic pathway to target inflammation and remodelling in asthma.

Seidel P, Sun Q, Costa L, Lardinois D, Tamm M, Roth M.

Cell Signal. 2016 Oct;28(10):1555-62. doi: 10.1016/j.cellsig.2016.07.004. Epub 2016 Jul 11.

PMID:
27418099
5.

Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study.

Mandal J, Malla B, Steffensen R, Costa L, Egli A, Trendelenburg M, Blasi F, Kostikas K, Welte T, Torres A, Louis R, Boersma W, Milenkovic B, Aerts J, Rohde GG, Lacoma A, Rentsch K, Roth M, Tamm M, Stolz D.

Respir Res. 2015 Dec 18;16:150. doi: 10.1186/s12931-015-0306-3.

6.

Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP.

Lambers C, Costa L, Ying Q, Zhong J, Lardinois D, Dekan G, Schuller E, Roth M.

Pharmacol Res. 2015 Dec;102:310-8. doi: 10.1016/j.phrs.2015.09.010. Epub 2015 Nov 4.

PMID:
26546746
7.

Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary Disease.

Mandal J, Roth M, Costa L, Boeck L, Rakic J, Scherr A, Tamm M, Stolz D.

Respiration. 2015;90(5):357-68. doi: 10.1159/000439228. Epub 2015 Oct 9.

8.

Longitudinal Measurement of Serum Vascular Endothelial Growth Factor in Patients with Chronic Obstructive Pulmonary Disease.

Boeck L, Mandal J, Costa L, Roth M, Tamm M, Stolz D.

Respiration. 2015;90(2):97-104. doi: 10.1159/000430993. Epub 2015 Jun 9.

9.

Extracellular matrix composition is modified by β₂-agonists through cAMP in COPD.

Lambers C, Qi Y, Eleni P, Costa L, Zhong J, Tamm M, Block LH, Roth M.

Biochem Pharmacol. 2014 Oct 1;91(3):400-8. doi: 10.1016/j.bcp.2014.07.026. Epub 2014 Aug 12.

PMID:
25107701
10.

Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.

Costa L, Roth M, Miglino N, Keglowich L, Zhong J, Lardinois D, Tamm M, Borger P.

Pulm Pharmacol Ther. 2014 Feb;27(1):29-37. doi: 10.1016/j.pupt.2013.11.001. Epub 2013 Nov 19.

PMID:
24269928
11.

In vitro wear performance of standard, crosslinked, and vitamin-E-blended UHMWPE.

Affatato S, Bracco P, Costa L, Villa T, Quaglini V, Toni A.

J Biomed Mater Res A. 2012 Mar;100(3):554-60. doi: 10.1002/jbm.a.33297. Epub 2011 Dec 12.

12.

Vitamin E blended UHMWPE may have the potential to reduce bacterial adhesive ability.

Banche G, Bracco P, Bistolfi A, Allizond V, Boffano M, Costa L, Cimino A, Cuffini AM, Del Prever EM.

J Orthop Res. 2011 Nov;29(11):1662-7. doi: 10.1002/jor.21432. Epub 2011 Apr 22.

13.

UHMWPE for arthroplasty: from powder to debris. Editorial comment: a perspective on polyethylene.

Kurtz SM, Costa L.

Clin Orthop Relat Res. 2011 Aug;469(8):2260-1. doi: 10.1007/s11999-011-1853-7. No abstract available.

14.

Europium stearate additives delay oxidation of UHMWPE for orthopaedic applications: a pilot study.

Gallardo LA, Carpentieri I, Laurent MP, Costa L, Wimmer MA.

Clin Orthop Relat Res. 2011 Aug;469(8):2294-301. doi: 10.1007/s11999-010-1711-z.

15.

Gas chromatography study of reagent degradation during chemical vapor deposition of carbon nanotubes.

Musso S, Zanetti M, Giorcelli M, Tagliaferro A, Costa L.

J Nanosci Nanotechnol. 2009 Jun;9(6):3593-8.

PMID:
19504887
16.

UHMWPE for arthroplasty: past or future?

Brach Del Prever EM, Bistolfi A, Bracco P, Costa L.

J Orthop Traumatol. 2009 Mar;10(1):1-8. doi: 10.1007/s10195-008-0038-y. Epub 2008 Dec 24.

17.

[CardiReset: general medicine and monitoring of cardiovascular risk factors in a whole region].

Vanuzzo D, Samani F, Canciani L, Paduano R, Pilotto L, Bader G, Mirolo R, Battigelli D, Panfilo M, Fattori MG, Simon G, Zanier L; Ricercatori CardioRESET.

G Ital Cardiol (Rome). 2009 Jan;10(1):37-43. Italian.

PMID:
19292018
18.

Oxidation and oxidation potential in contemporary packaging for polyethylene total joint replacement components.

Costa L, Bracco P, Brach del Prever EM, Kurtz SM, Gallinaro P.

J Biomed Mater Res B Appl Biomater. 2006 Jul;78(1):20-6.

PMID:
16470814
19.

Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: long-term results.

Chiesa F, Tradati N, Grigolato R, Boracchi P, Biganzoli E, Crose N, Cavadini E, Formelli F, Costa L, Giardini R, Zurrida S, Costa A, De Palo G, Veronesi U.

Int J Cancer. 2005 Jul 1;115(4):625-9.

20.

A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.

Damascelli B, Patelli GL, Lanocita R, Di Tolla G, Frigerio LF, Marchianò A, Garbagnati F, Spreafico C, Tichà V, Gladin CR, Palazzi M, Crippa F, Oldini C, Calò S, Bonaccorsi A, Mattavelli F, Costa L, Mariani L, Cantù G.

AJR Am J Roentgenol. 2003 Jul;181(1):253-60.

PMID:
12818869

Supplemental Content

Loading ...
Support Center